These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22044414)
1. Genetic and genomic predictors of anti-TNF response. Prajapati R; Plant D; Barton A Pharmacogenomics; 2011 Nov; 12(11):1571-85. PubMed ID: 22044414 [TBL] [Abstract][Full Text] [Related]
2. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]
3. Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions. Plenge RM; Criswell LA Curr Opin Rheumatol; 2008 Mar; 20(2):145-52. PubMed ID: 18349743 [TBL] [Abstract][Full Text] [Related]
4. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature. Ingegnoli F; Favalli EG; Meroni PL Autoimmun Rev; 2011 Jun; 10(8):460-3. PubMed ID: 21296193 [TBL] [Abstract][Full Text] [Related]
5. [Biopharmaceuticals in the treatment of rheumatoid arthritis]. Baslund B; Bendtzen K Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481 [TBL] [Abstract][Full Text] [Related]
6. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Iannaccone CK; Lee YC; Cui J; Frits ML; Glass RJ; Plenge RM; Solomon DH; Weinblatt ME; Shadick NA Rheumatology (Oxford); 2011 Jan; 50(1):40-6. PubMed ID: 20847201 [TBL] [Abstract][Full Text] [Related]
7. [Rituximab (Mabthera)--treatment of rheumatoid arthritis patients with inadequate response to TNF inhibitors--when to change therapy?]. Morović-Vergles J Reumatizam; 2008; 55(2):70-2. PubMed ID: 19024280 [TBL] [Abstract][Full Text] [Related]
8. Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Quartuccio L; Fabris M; Salvin S; Atzeni F; Saracco M; Benucci M; Cimmino M; Morassi P; Masolini P; Pellerito R; Cutolo M; Puttini PS; De Vita S Rheumatology (Oxford); 2009 Dec; 48(12):1557-9. PubMed ID: 19789202 [TBL] [Abstract][Full Text] [Related]
9. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents. Ranganathan P Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept]. Verhoeven AC; Boers M Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611 [No Abstract] [Full Text] [Related]
11. Emerging biologic drugs for the treatment of rheumatoid arthritis. Puppo F; Murdaca G; Ghio M; Indiveri F Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092 [TBL] [Abstract][Full Text] [Related]
12. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Belmonte Serrano MA; Pincus T Rheumatology (Oxford); 2010 Sep; 49(9):1795-6; author reply 1796-7. PubMed ID: 20484342 [No Abstract] [Full Text] [Related]
13. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature. Peyrin-Biroulet L Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972 [No Abstract] [Full Text] [Related]
14. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Cañete JD; Suárez B; Hernández MV; Sanmartí R; Rego I; Celis R; Moll C; Pinto JA; Blanco FJ; Lozano F Ann Rheum Dis; 2009 Oct; 68(10):1547-52. PubMed ID: 18930989 [TBL] [Abstract][Full Text] [Related]
15. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Wolfe F; Michaud K Am J Med; 2004 Mar; 116(5):305-11. PubMed ID: 14984815 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab. Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502 [TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596 [TBL] [Abstract][Full Text] [Related]
19. Associations between tumor necrosis factor-alpha (TNF-alpha) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-alpha blockers in rheumatoid arthritis: a metaanalysis update. Lee YH; Ji JD; Bae SC; Song GG J Rheumatol; 2010 Apr; 37(4):740-6. PubMed ID: 20194454 [TBL] [Abstract][Full Text] [Related]
20. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab. Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]